Daniel M Sullivan Selected Research

Daniel M Sullivan Research Topics

Disease

46	Neoplasms (Cancer) 12/2020 - 02/2003
18	Multiple Myeloma 12/2020 - 12/2006
9	Breast Neoplasms (Breast Cancer) 02/2018 - 05/2004
6	Hematologic Neoplasms (Hematological Malignancy) 01/2016 - 02/2003
4	Fatigue 10/2016 - 05/2011
4	Exanthema (Rash) 11/2014 - 02/2007
3	Melanoma (Melanoma, Malignant) 06/2009 - 12/2008
2	Neutropenia 10/2016 - 02/2016
2	Thrombocytopenia (Thrombopenia) 10/2016 - 02/2016
2	Diarrhea 10/2016 - 12/2011
2	Hyperglycemia 11/2014 - 12/2011
2	Neoplasm Metastasis (Metastasis) 08/2014 - 12/2008
2	Nausea 01/2014 - 12/2011
2	Stomach Neoplasms (Stomach Cancer) 11/2013 - 08/2008
2	Adenocarcinoma 12/2011 - 08/2008
2	Febrile Neutropenia 05/2011 - 05/2005
2	Lymphoma (Lymphomas) 05/2011 - 03/2007
2	Leukemia 03/2011 - 03/2007
2	Disease Progression 01/2008 - 02/2007
1	Fanconi Anemia (Fanconi's Anemia) 12/2020
1	Pathologic Complete Response 01/2020
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2016
1	Anemia 10/2016
1	Dehydration (Water Stress) 10/2016
1	Leukopenia 10/2016
1	Hypokalemia 10/2016
1	Autoimmune Diseases (Autoimmune Disease) 04/2016
1	Hypophysitis 04/2016
1	Brain Neoplasms (Brain Tumor) 04/2016
1	Heart Failure 02/2016
1	Osteosarcoma (Osteogenic Sarcoma) 11/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015
1	Ovarian Neoplasms (Ovarian Cancer) 04/2015
1	Fallopian Tube Neoplasms 04/2015
1	Prostatic Neoplasms (Prostate Cancer) 11/2014

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 01/2016 - 05/2006
12	Proteins (Proteins, Gene)FDA Link 07/2015 - 12/2005
8	Bortezomib (Velcade)FDA Link 11/2016 - 03/2011
5	selinexorIBA 12/2020 - 07/2015
5	Lenalidomide (CC 5013)FDA Link 01/2019 - 01/2013
5	Topoisomerase II InhibitorsIBA 01/2016 - 02/2003
4	Paclitaxel (Taxol)FDA LinkGeneric 01/2014 - 01/2006
3	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 06/2012
3	1-methyltryptophanIBA 02/2018 - 09/2014
3	EnzymesIBA 02/2018 - 01/2008
3	carfilzomibIBA 11/2016 - 01/2013
3	Topotecan (Hycamtin)FDA LinkGeneric 10/2016 - 12/2011
3	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2016 - 12/2010
3	Biomarkers (Surrogate Marker)IBA 11/2014 - 03/2007
3	MK 2206IBA 11/2014 - 12/2011
3	Carboplatin (JM8)FDA LinkGeneric 01/2014 - 01/2006
3	trioctyl phosphine oxide (TOPO)IBA 08/2006 - 02/2003
2	Exportin 1 ProteinIBA 12/2020 - 01/2016
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2019 - 01/2014
2	Matrix Metalloproteinase InhibitorsIBA 06/2017 - 04/2007
2	Proteasome InhibitorsIBA 11/2016 - 03/2011
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 10/2016 - 05/2011
2	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 04/2016 - 09/2014
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 08/2014
2	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 01/2014
2	1-dodecylpyridoxal (PLD)IBA 01/2016 - 01/2014
2	Docetaxel (Taxotere)FDA Link 09/2014 - 01/2014
2	Dasatinib (BMS 354825)FDA Link 01/2013 - 06/2009
2	Etoposide (VP 16)FDA LinkGeneric 12/2011 - 08/2006
2	Farnesyltranstransferase (Farnesyltransferase)IBA 03/2011 - 11/2004
2	DNA (Deoxyribonucleic Acid)IBA 04/2009 - 12/2008
2	Valproic Acid (Depakote)FDA LinkGeneric 04/2009 - 12/2005
2	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2008 - 02/2003
2	Biological ProductsIBA 08/2006 - 12/2005
2	taxaneIBA 01/2006 - 05/2005
2	BMS188797IBA 01/2006 - 05/2005
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 12/2005 - 02/2003
2	Histones (Histone)IBA 12/2005 - 05/2005
1	EltanexorIBA 12/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2020
1	VaccinesIBA 02/2018
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2017
1	Diphosphonates (Bisphosphonates)IBA 06/2017
1	3- (8- amino- 1- (2- phenylquinolin- 7- yl)imidazo(1,5- a)pyrazin- 3- yl)- 1- methylcyclobutanolIBA 10/2016
1	Alanine Transaminase (SGPT)IBA 10/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 04/2016
1	AutoantibodiesIBA 04/2016
1	Sorafenib (BAY 43-9006)FDA Link 02/2016
1	Phosphotransferases (Kinase)IBA 02/2016
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 01/2016
1	Drug CombinationsIBA 11/2015
1	Investigational DrugsIBA 11/2015
1	Gemcitabine FDA Link 07/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015
1	veliparibIBA 04/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2015
1	ICG 001IBA 01/2015
1	CateninsIBA 01/2015

Therapy/Procedure

24	Therapeutics 12/2020 - 11/2004
10	Drug Therapy (Chemotherapy) 12/2020 - 02/2003
1	Autologous Transplantation 12/2020
1	Induction Chemotherapy 01/2020
1	Castration 11/2014